Emergency Medicine Reports - March 20, 2005

Target Audience:

This activity is intended for the emergency physician.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Authors
Lisa Freeman Grossheim, MD, FACEP
Assistant Professor
Emergency Medicine
University of Texas Medical School at Houston

Monica Carvajal, MD
Resident Physician
Department of Emergency Medicine
University of Texas Medical School at Houston

Heidi Knowles-Ely, MD
Resident Physician
Department of Emergency Medicine
University of Texas Medical School at Houston

Peer Reviewers
Charles Emerman, MD
Professor and Chairman of Emergency Medicine
Case Western Reserve University
Cleveland, OH

Richard O. Gray, MD
Assistant Professor of Emergency Medicine
Hennepin County Medical Center
Minneapolis, MN

Editor-In-Chief
Gideon Bosker, MD
Special Clinical Projects and Medical
Education Resources
Assistant Clinical Professor
Section of Emergency Services
Yale University School of Medicine
Associate Clinical Professor
Oregon Health Sciences University

Subjects:

  • Treating Hypertension in the Emergency Department: First, Do No Harm, Part I

Objectives:

  • Quickly recognize or increase index of suspicion for specific conditions
  • Understand the epidemiology, etiology, pathophysiology, and clinical features of the entity discussed
  • Perform necessary diagnostic studies correctly
  • Take a meaningful patient history that will reveal the most important details about the particular medical problem discussed
  • Apply state-of-the-art therapeutic techniques (including the implications of pharmaceutical therapy discussed) to patients with the particular medical problems discussed
  • Have an understanding of the differential diagnosis of the entity discussed
  • Understand both likely and rare complications that may occur
  • Provide patients with any necessary discharge instructions

Financial Disclosure:

To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose Charles Emerman, MD (peer reviewer) is a consultant for Scios, Aventis, and Sepracor; serves on the speaker’s bureau for Scios, Aventis, Sepracor, Pfizer, Bayer, and Roche; and has conducted research for Scios, Aventis, and Sepracor. Lisa Freeman Grossheim, MD, FACEP, Monica Carvajal, MD, Heidi Knowles-Ely, MD (authors), and Richard O. Gray, MD (peer reviewer) report no relationships with companies related to the field of study covered by this CME program. Gideon Bosker, MD, FACEP (editor) has been compensated for speaking engagements and/or editorial services related to production of peer-reviewed Clinical Consensus Reports under the auspices of unrestricted educational grants for Pfizer, Sanofi-Aventis, Bristol-Myers Squibb, Roche Pharmaceuticals, Bayer, Novartis, Forest Pharmaceuticals, and Schering Plough Corporation. Dr. Bosker also acknowledges that he has received royalties, commissions, and other compensation relating to the sale of textbooks, reprints of articles, and/or other electronic or print materials to the following pharmaceutical companies: Pfizer, Sanofi-Aventis, Bayer, Roche, Forest Laboratories, and Novartis. He is a minor stockholder in Pfizer. Any other stock ownership which he may have in other pharmaceutical companies is managed in blinded fashion by an independent consultant without Dr. Bosker’s input or consultation.

Copyright 2005 AHC Media. All rights reserved.